LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients

This single-center, observational study evaluated the LVAD index, defined as device-estimated pump flow divided by body surface area, in adult patients supported with continuous-flow left ventricular assist devices. The study included 34 patients with end-stage heart failure who had either an HVAD or HeartMate 3 device and were followed for six months. The study assessed the relationship between LVAD index and selected routine biochemical markers related to hepatic and renal status, including ALT, AST, LDH, BUN, and creatinine. The study also evaluated whether LVAD index was associated with rehospitalization during follow-up.

NCT Number	NCT07633535
Lead Sponsor	Gaziantep City Hospital Collaborators: Antalya City Hospital, Akdeniz University Hospital
Conditions	End-stage Heart Failure, Left Ventricular Assist Device, Mechanical Circulatory Support
Enrollment	34 participants
Start Date	2022-10-01
Primary Completion	2023-04-30 (estimated)
Study Completion	2023-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-08